Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,035,767
+$256,699 QoQ
Shares Held
8,090
-1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#1,946
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEST PACES ADVISORS INC. holds $9,117,824 across 12 Drug Manufacturers - General names. ABBV ranks #3 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,426 | $2,909,817 | |
| 2 | JNJ |
Johnson & Johnson
|
9,783 | $2,484,588 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
8,090 | $2,035,767 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,717 | $863,134 | |
| 5 | AMGN |
Amgen Inc
|
1,126 | $407,747 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,222 | $280,727 | |
| 7 | PFE |
Pfizer Inc
|
2,704 | $65,112 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
648 | $37,337 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,035,767 | 8,090 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,779,068 | 8,180 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,063,950 | 9,033 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,122,064 | 9,165 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,710,859 | 9,217 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,916,060 | 9,145 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,605,519 | 9,035 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,885,539 | 9,548 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,679,523 | 9,792 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,793,138 | 9,847 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,573,410 | 10,153 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $1,453,931 | 9,754 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $1,317,389 | 9,778 | Shares | Sole | 2023-12-18 | |
| 2023-03-31 | $1,549,713 | 9,724 | Shares | Sole | 2023-12-18 | |
| 2022-12-31 | $1,531,093 | 9,474 | Shares | Sole | 2023-12-18 | |
| 2022-09-30 | $1,278,618 | 9,527 | Shares | Sole | 2023-12-19 | |
| 2022-06-30 | $1,464,669 | 9,563 | Shares | Sole | 2023-12-19 | |
| 2022-03-31 | $1,516,376 | 9,354 | Shares | Sole | 2023-12-19 | |
| 2021-12-31 | $1,323,399 | 9,774 | Shares | Sole | 2023-12-20 | |
| 2021-09-30 | $1,014,948 | 9,409 | Shares | Sole | 2023-12-20 | |
| 2021-06-30 | $1,059,041 | 9,402 | Shares | Sole | 2023-12-20 | |
| 2021-03-31 | $1,054,387 | 9,743 | Shares | Sole | 2023-12-20 | |
| 2020-12-31 | $989,637 | 9,236 | Shares | Sole | 2023-12-20 | |
| 2020-09-30 | $726,121 | 8,290 | Shares | Sole | 2023-12-20 | |
| 2020-06-30 | $817,937 | 8,331 | Shares | Sole | 2023-12-20 | |
| 2020-03-31 | $252,646 | 3,316 | Shares | Sole | 2023-12-21 | |
| No filing history on record for this holder in this stock. | ||||||